🧬 SEMAX (10mg) — High‑Purity Heptapeptide for Neuromodulation & Stress‑Response Research
SEMAX (10mg) is a high‑purity, research‑grade synthetic heptapeptide derived from the ACTH(4‑10) fragment, widely referenced in Canadian laboratory environments for studies involving neuromodulation, cognitive‑pathway signaling, stress‑response modeling, and peptide–receptor interaction dynamics.
Engineered for in‑vitro and preclinical research, SEMAX is valued for its stability, mechanistic specificity, and broad relevance to neurochemical signaling pathways, making it a preferred peptide for Canadian researchers studying central‑pathway regulation, transcriptional activity, and peptide‑mediated cellular communication.
🔍 What Is SEMAX?
SEMAX is a synthetic ACTH‑derived heptapeptide designed for controlled research use in studies involving:
Neuromodulatory signaling pathways
Peptide–receptor interaction models
Stress‑response and adaptation mechanisms
Cognitive‑pathway transcriptional activity
Peptide stability and degradation‑resistance profiling
Multi‑pathway neurochemical investigations
Its compact structure and predictable behavior make SEMAX a widely used model compound for neurobiological, biochemical, and peptide‑mechanism research across Canada.
📡 Mechanistic Overview
🔷 Neuromodulatory Signaling
Referenced in studies involving ACTH‑fragment signaling
Supports mapping of neurochemical pathway activation
Used in models examining peptide‑mediated receptor interactions
🔶 Stress‑Response & Adaptation Pathways
Applied in research involving oxidative‑stress markers
Supports investigations into cellular resilience and adaptive signaling
Used in multi‑pathway stress‑response modeling
🔵 Transcriptional & Peptide‑Interaction Dynamics
Examined in studies involving transcriptional‑cascade activity
Supports peptide–protein interaction modeling
Used in comparative studies vs. other ACTH‑derived fragments
🧱 Structural Overview
🧪 Molecular Composition
Type: Synthetic heptapeptide
Form: Lyophilized powder (10mg fill)
Identity: Verified via MS and HPLC/UPLC
Origin: Derived from ACTH(4‑10) sequence
🧬 Functional Domains
Neuromodulation domain: ACTH‑fragment signaling
Stress‑response domain: Oxidative‑marker and adaptation models
Interaction domain: Peptide–protein binding and structural modeling
🎯 Pathway Targets
Neurochemical signaling pathways
Stress‑response and adaptation markers
Transcriptional‑activation cascades
Peptide–receptor interaction networks
🔬 Research Focus Areas
SEMAX is referenced in research involving:
Neuromodulation and cognitive‑pathway modeling
Stress‑response and oxidative‑marker studies
Peptide‑receptor interaction assays
Transcriptional‑cascade and signaling‑pathway mapping
Comparative ACTH‑fragment analysis
Multi‑pathway neurochemical investigations
Its clean mechanistic profile makes it suitable for controlled, pathway‑specific research environments across Canada.
🇨🇦 Optimized for Canadian Research Environments
BlueNexLabs supplies SEMAX to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and Canada‑wide, offering:
High‑purity, COA‑verified peptide materials
Consistent batch quality and traceability
Audit‑safe RUO labeling
Fast, Canada‑wide fulfillment
Research‑focused support for neurochemical and signaling‑pathway studies
This ensures Canadian researchers have reliable access to premium ACTH‑derived peptides for advanced mechanistic modeling.
Each batch includes:
MS identity confirmation
HPLC purity profile
Solvent system details
RUO‑only designation
All documentation is structured for audit‑safe compliance and laboratory reproducibility.
❄️ Storage & Handling
Store lyophilized peptide at –20°C, protected from light and humidity
Reconstituted solutions should be stored at 2–8°C
Avoid repeated freeze–thaw cycles
Use sterile technique during preparation
⚠️ Compliance Notice
SEMAX is supplied for laboratory research only. Not for human or veterinary use. No therapeutic, cognitive, or performance‑related claims are made or implied.
🧬 SEMAX (10mg) — High‑Purity Heptapeptide for Neuromodulation & Stress‑Response Research
SEMAX (10mg) is a high‑purity, research‑grade synthetic heptapeptide derived from the ACTH(4‑10) fragment, widely referenced in Canadian laboratory environments for studies involving neuromodulation, cognitive‑pathway signaling, stress‑response modeling, and peptide–receptor interaction dynamics.
Engineered for in‑vitro and preclinical research, SEMAX is valued for its stability, mechanistic specificity, and broad relevance to neurochemical signaling pathways, making it a preferred peptide for Canadian researchers studying central‑pathway regulation, transcriptional activity, and peptide‑mediated cellular communication.
🔍 What Is SEMAX?
SEMAX is a synthetic ACTH‑derived heptapeptide designed for controlled research use in studies involving:
Neuromodulatory signaling pathways
Peptide–receptor interaction models
Stress‑response and adaptation mechanisms
Cognitive‑pathway transcriptional activity
Peptide stability and degradation‑resistance profiling
Multi‑pathway neurochemical investigations
Its compact structure and predictable behavior make SEMAX a widely used model compound for neurobiological, biochemical, and peptide‑mechanism research across Canada.
📡 Mechanistic Overview
🔷 Neuromodulatory Signaling
Referenced in studies involving ACTH‑fragment signaling
Supports mapping of neurochemical pathway activation
Used in models examining peptide‑mediated receptor interactions
🔶 Stress‑Response & Adaptation Pathways
Applied in research involving oxidative‑stress markers
Supports investigations into cellular resilience and adaptive signaling
Used in multi‑pathway stress‑response modeling
🔵 Transcriptional & Peptide‑Interaction Dynamics
Examined in studies involving transcriptional‑cascade activity
Supports peptide–protein interaction modeling
Used in comparative studies vs. other ACTH‑derived fragments
🧱 Structural Overview
🧪 Molecular Composition
Type: Synthetic heptapeptide
Form: Lyophilized powder (10mg fill)
Identity: Verified via MS and HPLC/UPLC
Origin: Derived from ACTH(4‑10) sequence
🧬 Functional Domains
Neuromodulation domain: ACTH‑fragment signaling
Stress‑response domain: Oxidative‑marker and adaptation models
Interaction domain: Peptide–protein binding and structural modeling
🎯 Pathway Targets
Neurochemical signaling pathways
Stress‑response and adaptation markers
Transcriptional‑activation cascades
Peptide–receptor interaction networks
🔬 Research Focus Areas
SEMAX is referenced in research involving:
Neuromodulation and cognitive‑pathway modeling
Stress‑response and oxidative‑marker studies
Peptide‑receptor interaction assays
Transcriptional‑cascade and signaling‑pathway mapping
Comparative ACTH‑fragment analysis
Multi‑pathway neurochemical investigations
Its clean mechanistic profile makes it suitable for controlled, pathway‑specific research environments across Canada.
🇨🇦 Optimized for Canadian Research Environments
BlueNexLabs supplies SEMAX to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and Canada‑wide, offering:
High‑purity, COA‑verified peptide materials
Consistent batch quality and traceability
Audit‑safe RUO labeling
Fast, Canada‑wide fulfillment
Research‑focused support for neurochemical and signaling‑pathway studies
This ensures Canadian researchers have reliable access to premium ACTH‑derived peptides for advanced mechanistic modeling.
Each batch includes:
MS identity confirmation
HPLC purity profile
Solvent system details
RUO‑only designation
All documentation is structured for audit‑safe compliance and laboratory reproducibility.
❄️ Storage & Handling
Store lyophilized peptide at –20°C, protected from light and humidity
Reconstituted solutions should be stored at 2–8°C
Avoid repeated freeze–thaw cycles
Use sterile technique during preparation
⚠️ Compliance Notice
SEMAX is supplied for laboratory research only. Not for human or veterinary use. No therapeutic, cognitive, or performance‑related claims are made or implied.
